BioTuesdays

Category - Markets

Senseonics
Markets

Stifel starts Senseonics at buy; PT $2

Stifel initiated coverage of Senseonics Holdings (NYSE American:SENS) with a “buy” rating and $2 price target. The stock closed at 95 cents on Oct. 22. Senseonics is an emerging company with a long-duration, implantable...

October 23, 2019
Dynavax
Markets

HCW starts Dynavax Technologies at buy; PT $13

H.C. Wainwright initiated coverage of Dynavax Technologies (NASDAQ:DVAX) with a “buy” rating and $13 price target based on an outlook for the sales growth of the company’s marketed hepatitis B vaccine, Heplisav-B. The...

October 18, 2019
Dyadic
Markets

Dawson James starts Dyadic at buy; PT $14

Dawson James Securities launched coverage of Dyadic International (NASDAQ:DYAI) with a “buy” rating and $14 price target. The stock closed at $6.66 on Oct. 15. Dyadic has been developing a gene expression platform over...

October 16, 2019
IGM Biosciences
Markets

Stifel starts IGM Biosciences at buy; PT $32

Stifel launched coverage of IGM Biosciences (NASDAQ:IGMS) with a “buy” rating and $32 price target. The stock closed at $17.25 on Oct. 11. “We believe the company’s first/only-in-class, IgM-based antibody platform...

October 14, 2019
Exagen
Markets

WB starts Exagen at outperform

William Blair initiated coverage of Exagen (NASDAQ:XGN) with an “outperform” rating based on an outlook for business trends, potential upside to revenue estimates, and its relative valuation to comparable diagnostic...

October 11, 2019
Aravive Logo
Markets

HCW starts Aravive at buy; PT $18

H.C. Wainwright launched coverage of Aravive (NASDAQ:ARAV) with a “buy” rating and $18 price target. The stock closed at $6.38 on Oct. 9. The company’s lead asset is AVB-500, an anti-GAS6 selective decoy, used to...

October 10, 2019
Markets

SVB Leerink starts Mereo BioPharma at OP; PT $8

SVB Leerink initiated coverage of Mereo BioPharma Group PLC (NASDAQ:MREO) with an “outperform” rating and price target of $8. The stock closed at $2.89 on Oct. 9. “We believe this rare disease-focused biopharma company...

October 10, 2019
Vericel Logo
Markets

HCW starts Vericel at buy; PT $19

H.C. Wainwright initiated coverage of Vericel (NASDAQ:VCELL) with a “buy” rating and $19 price target. The stock closed at $13.82 on Oct. 8. Vericel, a commercial wound care company, markets two innovative tissue...

October 9, 2019